Histopathological Subtype and Cancer Stem Cell Marker Expression in Advanced Epithelial Ovarian Cancer: A Two-Year Progression-Free Survival Study
World Journal of Oncology · 2026-12 · 17 (6) · 802-810
DOI: 10.14740/wjon2802 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Oncology, 2026-12. Verfasst von I. Nyoman Gede Budiana und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Budiana, I. N. G., & Saspriyana, K. Y. (2026). Histopathological Subtype and Cancer Stem Cell Marker Expression in Advanced Epithelial Ovarian Cancer: A Two-Year Progression-Free Survival Study. World Journal of Oncology, 17(6), 802-810. https://doi.org/10.14740/wjon2802
Vancouver
Budiana ING, Saspriyana KY. Histopathological Subtype and Cancer Stem Cell Marker Expression in Advanced Epithelial Ovarian Cancer: A Two-Year Progression-Free Survival Study. World Journal of Oncology. 2026;17(6):802-810. doi:10.14740/wjon2802
BibTeX
@article{Budiana2026,
author = {Budiana, I. Nyoman Gede and Saspriyana, Kade Yudi},
title = {Histopathological Subtype and Cancer Stem Cell Marker Expression in Advanced Epithelial Ovarian Cancer: A Two-Year Progression-Free Survival Study},
journal = {World Journal of Oncology},
year = {2026},
volume = {17},
number = {6},
pages = {802--810},
doi = {10.14740/wjon2802}
}
EUVIMED